# FDA 483 - G21 USA, Inc. - July 25, 2023

Source: https://www.keypedia.com/records/483/g21-usa-inc/52fb52de-54e0-4d9b-88b7-b4fa2e5dd63d

> FDA 483 for G21 USA, Inc. on July 25, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: G21 USA, Inc.
- Inspection Date: 2023-07-25
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: An FDA inspection of G21 USA, Inc., an initial importer in New York, revealed significant deficiencies in their quality system. The firm lacked adequate procedures for handling customer complaints, implementing corrective and preventive actions, and documenting personnel training. These issues indicate a need for comprehensive improvements in their operational controls.

## Related Documents

- [483 - 2023-07-25](https://www.keypedia.com/records/483/g21-usa-inc/51707bea-7bae-48c6-9380-c00b1aab69bf)

## Related Officers

- [Tanvir Kaium](https://www.keypedia.com/people/tanvir-kaium/4efaaf7b-78f1-4bd3-876b-9a9aa0ab3c57)
- [Colin E. Tack](https://www.keypedia.com/people/colin-e-tack/5bdbf977-d4ac-48fe-81cc-ada89379ed0d)

Company: https://www.keypedia.com/companies/g21-usa-inc/4be84097-8947-4771-b34c-8c54e34cd94b

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961